Metfaith PG 2mg/500mg/15mg Tablet SR
Marketer
Indiabulls pharmaceutical ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metfaith PG 2mg/500mg/15mg Tablet SR
GlucoTrim Trio 2mg/500mg/15mg Extended-Release Tablets combine three active ingredients to manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and frequency for GlucoTrim Trio. Take with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, omit the missed dose and resume your normal schedule. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases the risk of hypoglycemia. Regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your doctor of any pre-existing kidney, liver, or heart conditions before initiating treatment. Pregnant or lactating individuals should seek medical advice prior to use. Kidney function tests will be conducted before commencing therapy. Limit alcohol consumption as it may amplify adverse effects.
Uses of Metfaith PG 2mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Metfaith PG 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Metfaith PG 2mg/500mg/15mg Extended-Release Tablets with food.
Common Side effects of Metfaith PG 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metfaith PG 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. The Metfaith PG 2mg/500mg/15mg Extended-Release tablet should be taken with a meal.
How Metfaith PG 2mg/500mg/15mg Tablet SR works:
Metfaith PG 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Metfaith PG 2mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metfaith PG 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Metfaith PG 2mg/500mg/15mg tablets are likely not suitable for breastfeeding mothers. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Metfaith PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is necessary. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Metfaith PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Metfaith PG 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Metfaith PG 2mg/500mg/15mg Tablet SR :
Should you forget to take a Metfaith PG 2mg/500mg/15mg Tablet SR, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Metfaith PG 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently